CClinicalTrials.gg
CompletedNCT04618224wDDARTUpdated Feb 16, 2021

Development and Validation of an Internet-based Near and Intermediate-vision Reading Test

An observational study in Presbyopia, Refractive Errors and Low Vision, sponsored by Democritus University of Thrace. Completed at 2 sites in Greece. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-02-16.

Sponsored by Democritus University of Thrace · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Primary objective of our study is to develop and validate an internet-based digital near and intermediate-vision reading test in the greek language.

Read the detailed description

Present study aims to develop and validate a computer-based digital near-vision reading test (web Democritus Digital Acuity Reading Test - wDDART) based on the validated digital DDART.

Specifically, present study aims to develop a new online reading test (wDDART) based on the corresponding digital DDART reading test for Windows and to evaluate the level of agreement between the two reading tests, as well as test-retest reliability of the online wDDART reading test.

The first part of the study is the development of the online reading test, which will include the following new smart features:

  1. Automatic calculation of the reading time of each sentence (each logMAR)
  2. Automatic calculation of the basic reading parameters - RA, MRS, CPS, ACC - immediately after the completion of the examination
  3. Adjustment of the font size according to the size of the computer screen used for the examination
  4. Real time calculation of the patient-screen distance through a face detection system

The second part of this study is the clinical validation of the online wDDART reading test. In this part, four reading parameters measured with the digital and the online version are compared. These parameters are the following:

  1. Reading Acuity (RA)
  2. Maximum Reading Speed (MRS)
  3. Critical Print Size (CPS)
  4. Accessibility Index (ACC) All the comparisons take place in two groups: a) a Normal Vision Group (NVG), and b) a Low Vision Group (LVG) in order to estimate the reading capacity in a population with a wide range of vision.
02

Conditions studied

  • Presbyopia
  • Refractive Errors
  • Low Vision
  • Near Vision
  • Reading

Keywords

  • internet-based digital reading test
  • smart features
  • face detection
  • reading acuity
  • reading speed
  • critical print size
03

In context

Vision, Low

214 studies on the registry are indexed under Vision, Low; 41 are open to participants now.

This study's enrollment of 100 is below the median of 141 across 51 observational studies indexed under Vision, Low.

Browse Vision, Low studies →

Lead sponsor

Democritus University of Thrace is the lead sponsor of 70 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Normal- and low-sighted participants aged 18 to 75 years

Inclusion criteria

  • Adequate literacy of written Greek language
  • Age between 18 to 75 years

Exclusion criteria

Exclusion Criteria:

  • Dyslexia
  • Attention-deficiency
  • Former diagnosis of mental and/or psychiatric diseases
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (actual)
Patient registry
No

Groups and cohorts

  • Control group

    * 70 patients with normal vision (NVG) with adequate literacy of written Greek language * 30 patients with low vision (LVG) with adequate literacy of written Greek language These patients are tested on the digital reading test DDART.

    Diagnostic Test: DDART Testing

  • Study group

    The same patients as those in the control group (NVG, LVG) are tested on the online version of the Greek digital reading test DDART (wDDART).

    Diagnostic Test: wDDART Testing

Interventions

  • Diagnostic testDDART Testing

    One randomly selected eye is included for each study participant. Participants respond to the DDART near vision test with defined environmental conditions at 40 cm viewing distance. All four parameters (RA, MRS, CPS and ACC) are evaluated.

  • Diagnostic testwDDART Testing

    One randomly selected eye is included for each study participant. Participants respond to the wDDART near vision test with defined environmental conditions at 40 cm viewing distance. All four parameters (RA, MRS, CPS and ACC) are evaluated.

06

What researchers measure

Primary outcomes

  1. Reading Acuity (RA)

    The smallest print that can be read by the patient easily (measured in logMAR). It is calculated by the following formula: RA = 1.4 - (sentences x 0.1) + (errors x 0.01).

    Time frame: through study completion, an average of 3 months

  2. Maximum Reading Speed (MRS)

    The patient's reading speed (measured in wpm) when reading is not limited by print size. It is calculated by averaging the reading speed of the sentences with print size larger than the CPS.

    Time frame: through study completion, an average of 3 months

  3. Critical Print Size (CPS)

    The smallest print size (measured in logMAR) that can be read with the MRS, i.e., with speed greater than or equal to the average reading speed of the larger logMAR print sentences minus 1.96 times the standard deviation (SD) of the reading speed of these sentences.

    Time frame: through study completion, an average of 3 months

  4. Accessibility Index (ACC)

    The mean reading speed of the 10 largest print sizes at 40 cm (1.3 to 0.4 logMAR), divided by 200 wpm, which is the mean reading speed of normally sighted young adults aged 18 to 39 years old. This parameter was designed for better evaluation of one's access to text across the range of the 10 most common print sizes found in everyday life. For instance, a value of 0 means no access to commonly encountered printed material, while 1.0 is the mean value for normally sighted young adults that indicates reading fluency within the everyday life print sizes.

    Time frame: through study completion, an average of 3 months

Secondary outcomes

  1. Intraclass Correlation Coefficients (ICCs) for study participants

    Level of agreement between the digital and the online version are evaluated by calculation of the ICCs for the 4 reading parameters (RA, MRS, CPS, ACC).

    Time frame: through study completion, an average of 3 months

Other outcomes

  1. Test-retest Intraclass Correlation Coefficients (ICCs)

    Test-retest reliability of the internet-based reading test wDDART is evaluated by ICCs for the 4 reading parameters (RA, MRS, CPS, ACC).

    Time frame: through study completion, an average of 3 months

07

Study locations

2 sites
  • Department of Ophthalmology, University Hospital of Alexandroupolis
    Alexandroupolis, Evros 68100, Greece
  • Department of Computer Science and Biomedical Informatics, University of Thessaly
    Lamía, Thessaly 35100, Greece
08

References and documents

Publications

  • Labiris G, Panagiotopoulou EK, Chatzimichael E, Tzinava M, Mataftsi A, Delibasis K. Introduction of a digital near-vision reading test for normal and low vision adults: development and validation. Eye Vis (Lond). 2020 Oct 22;7:51. doi: 10.1186/s40662-020-00216-0. eCollection 2020. PubMed 33102611 ↗
  • Labiris G, Panagiotopoulou EK, Duzha E, Tzinava M, Perente A, Konstantinidis A, Delibasis K. Development and Validation of a Web-Based Reading Test for Normal and Low Vision Patients. Clin Ophthalmol. 2021 Sep 22;15:3915-3929. doi: 10.2147/OPTH.S314943. eCollection 2021. PubMed 34588763 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 16, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04618224
Lead sponsor
Democritus University of Thrace
Collaborators
University of Thessaly
Responsible party
Georgios Labiris (Professor (Associate) of Democritus University of Thrace, Democritus University of Thrace) — Principal investigator
First posted
Nov 5, 2020
Start date
Dec 2, 2020
Primary completion
Jan 15, 2021
Completion
Feb 10, 2021
Last update
Feb 16, 2021

Study contacts

Georgios Labiris, MD, PhD
study chair · Department of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion